Form 4 for YCBD cbdMD, Inc.
Accepted 2025-12-02 00:00:00 ET · period of report 2025-11-28 · accession 0001437749-25-036688 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | 2025-11-28 | YCBD | Kennedy Thomas Ronan | CEO, CFO, Dir | A - Grant | — | +445.0K | 513.7K | +648% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-28 | A | A | 445,000 | — | 513,722 | D | — | — | (F1) The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval. (F2) The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error. |